R RALLYBIO CORP
| Market Cap | $44.59M |
| P/E Ratio | — |
| Forward P/E | -1.56 |
| Dividend Yield | — |
| Beta | -1.20 |
| 52W Range | $2.00 - $10.97 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.01% | $2.88M | 4,194,777 | — |
Insider Trading
| Insider Name of the company insider who made the trade 1 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Lieber Jonathan IChief Financial Officer | Sale | 789 | $5.06 | $3.99K | 23 Feb 2026 | 23 Feb 2026 |
Frequently Asked Questions
What is RLYB stock price today?
RALLYBIO CORP (RLYB) is currently trading at $8.43. The stock has a 52-week range of $2.00 to $10.97 and a market capitalization of $44.59M.
Is RLYB a good stock to buy in 2026?
RALLYBIO CORP has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +89.0%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling RLYB stock?
There have been 1 insider transactions for RLYB in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has RLYB stock performed over the past year?
RALLYBIO CORP (RLYB) has returned +89.0% over the past 12 months. The stock traded between $2.00 and $10.97 during this period, and is currently at $8.43.
Which hedge funds own RLYB (RALLYBIO CORP)?
1 tracked hedge funds currently hold RLYB in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is RLYB's market cap and valuation?
RALLYBIO CORP (RLYB) has a market capitalization of $44.59M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is RLYB's revenue and profitability?
RALLYBIO CORP reported revenue of $858.00K with net income of N/A and a profit margin of N/A. The stock has a beta of N/A.
What sector is RLYB in and who are its biggest institutional holders?
RALLYBIO CORP (RLYB) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.